NSF, also known as nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy, has been linked to a gadolinium-based contrast agent that has been used in 200 million MRI procedures. Dating back to 2006, investigative authorities and Omniscan, the manufacturer, had begun to receive reports of nephrogenic systemic fibrosis in people that were given the gadolinium-based contrast…
Continue reading ›For Injury Cases




